Welcome to our dedicated page for HAGERTY SEC filings (Ticker: HGTY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Hagerty, Inc. (NYSE: HGTY) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, including current reports on Form 8-K and other key documents filed with the U.S. Securities and Exchange Commission. These filings offer detailed insight into Hagerty’s specialty vehicle insurance operations, marketplace activities, partnerships and capital markets transactions.
Hagerty uses Form 8-K to report material events such as quarterly financial results, outlook updates, underwriting and reinsurance arrangements, and equity offerings. For example, the company has filed 8-Ks describing its results of operations and financial condition for specific quarters, including revenue, written premium, earned premium, loss ratios, membership and marketplace revenue, operating income, net income and Adjusted EBITDA. Other 8-Ks document a secondary public offering of Class A common stock, including the underwriting agreement and related legal opinions.
Filings also explain Hagerty’s relationships with Markel Group Inc. and Essentia Insurance Company. A July 2025 8-K outlines a proposed fronting arrangement under which Hagerty’s underwriting and claims authorities would be expanded and Hagerty Reinsurance Limited would assume 100% of the risk on policies written through Essentia. A January 2026 8-K reports consummation of this arrangement through a Sixth Amended and Restated Master Relationship Agreement, a Seventh Amended and Restated Limited Liability Company Agreement for The Hagerty Group, LLC, a General Agency Agreement and a new Quota Share Reinsurance Agreement, with Hagerty Re assuming 100% of the risk on specified Essentia policies effective January 1, 2026.
By reviewing these filings, investors can see how Hagerty structures its insurance programs, reinsurance, carrier partnerships and governance arrangements, as well as how it communicates financial performance and capital markets activity. Stock Titan supplements the raw documents with AI-powered tools that help users quickly identify key terms, track new filings as they appear on EDGAR and navigate to items related to earnings, material agreements and other significant events.
Patrick McClymont, the Chief Financial Officer of Hagerty, Inc. (HGTY), reported two Section 16 transactions. On 10/01/2025 he disposed of 8,111 shares of Class A common stock at $11.95 per share, identified as tax withholding upon RSU vesting from a 10/01/2022 grant. On 10/02/2025 he acquired 461 shares under the company Employee Stock Purchase Plan for the April 1–September 30, 2025 offering period at a price equal to 95% of the closing price on 10/01/2025 (reported as $11.35). Beneficial ownership moved from 313,746 to 314,207 shares following these transactions. The Form 4 was signed by a Power of Attorney on 10/03/2025.
Hagerty, Inc. insider Diana Chafey, who serves as Chief Legal Officer, reported two transactions in early October 2025. On 10/01/2025 she disposed of 1,076 shares of Class A common stock at $11.95 per share; the filing explains these were shares withheld for taxes when restricted stock units vested from an award dated 10/01/2023. On 10/02/2025 she acquired 993 shares under Hagerty's Employee Stock Purchase Plan for the April 1–September 30, 2025 offering period, at a per‑share price equal to 95% of the closing price on 10/01/2025 ($11.35 shown). The Form 4 was signed via power of attorney on 10/03/2025.
Hagerty, Inc. (HGTY) reported an equity award to its Chief Accounting Officer on a Form 4. On October 1, 2025, the officer acquired 8,306 shares of Class A common stock underlying restricted stock units at a stated price of $0.
The RSUs vest in equal installments on each annual anniversary of the grant date through October 1, 2028, subject to continued service, with exceptions for death, disability, retirement, or a change of control. Following this grant, the reporting person beneficially owned 90,797 shares directly.
Hagerty, Inc. (HGTY) filed a Form 144 notice reporting a proposed sale of 21,314 common shares through Merrill Lynch on the NYSE with an aggregate market value of $255,342. The filing states these shares were originally acquired on 12/02/2021 by Aldel LLC as part of a PIPE financing tied to the company’s business combination with Hagerty. The issuer’s total shares outstanding is listed as 90,942,223. The filing also discloses extensive prior open-market sales by Robert I. Kauffman / Aldel LLC across many dates from 06/16/2025 through 10/01/2025, including several large daily transactions such as 110,600 shares on 07/24/2025. The filer affirms no undisclosed material nonpublic information in connection with the sale.
Hagerty, Inc. (HGTY) filed a Form 144/A reporting a proposed sale of 18,372 shares of common stock through Merrill Lynch (New York) with an aggregate market value of $221,566, with an approximate sale date of 10/01/2025. The filing shows 90,942,223 shares outstanding. The securities being offered were originally acquired on 12/02/2021 by Aldel LLC as part of a PIPE financing announced in an 8-K, with 3,500,000 shares recorded as acquired and payment characterized as stock. The filing also lists extensive dispositions by Robert I. Kauffman/Aldel LLC during the prior three months, with numerous sales between 06/16/2025 and 09/30/2025 totaling many tens of thousands of shares and gross proceeds shown per sale. The notice includes the standard seller representation that no undisclosed material adverse information is known.
Hagerty, Inc. (HGTY) Form 144 notifies the SEC of a proposed sale of 30,187 common shares through Merrill Lynch with an aggregate market value of $361,036, planned approximately on 09/30/2025 on the NYSE. The shares were originally acquired on 12/02/2021 by Aldel LLC as part of a PIPE related to Hagerty's business combination; Aldel reports 3,500,000 shares acquired on that date. The filing lists multiple recent sales by Robert I. Kauffman/Aldel LLC from June through September 2025, including several large blocks, and states the filer represents no undisclosed material adverse information.
Hagerty, Inc. (HGTY) Form 144 filing: Aldel LLC (associated with Robert I. Kauffman) proposes to sell 5,506 shares of Hagerty common stock with an aggregate market value of $64,809, to be sold approximately on 09/29/2025 on the NYSE. The filing states these shares were originally acquired by Aldel LLC on 12/02/2021 as part of a PIPE financing tied to Hagerty Inc. The filer reports numerous secondary market sales by Robert I. Kauffman/Aldel LLC between 06/16/2025 and 09/22/2025, with individual sale amounts and gross proceeds listed in the filing.
Hagerty, Inc. director Robert I. Kauffman reported insider sales of Class A common stock on 09/22/2025. The filing shows a disposition of 34,447 shares at a weighted-average price of $12.38, and an additional reported disposition of 67,302 shares on the same date. The disclosure states the 34,447-share sale was executed under a Rule 10b5-1 trading plan adopted August 9, 2024. After these transactions the reporting person is shown as beneficially owning 1,186,942 shares indirectly through Aldel LLC, for which he is the manager with voting and investment discretion.
Hagerty, Inc. (HGTY) Form 144 filing reports a proposed sale of 34,447 common shares through Merrill Lynch (NYSE) with an aggregate market value of $426,608. The filing states these shares were acquired on 12/02/2021 by Aldel LLC as part of a PIPE related to Hagerty's business combination. The report also lists numerous dispositions by Robert I. Kauffman / Aldel LLC over the past three months, showing regular sales activity. The filing includes the usual Rule 144 representation that the seller is not aware of undisclosed material adverse information.
Robert I. Kauffman, a director of Hagerty, Inc. (HGTY) and manager of Aldel LLC, reported multiple dispositions of Class A common stock under a Rule 10b5-1 plan. On 09/15/2025 he sold 11,433 shares at a weighted-average price of $12.79. On 09/16/2025 he sold 17,622 shares at a weighted-average price of $12.46. The filing also records an additional disposition of 67,302 shares (disposition line present without accompanying date or price details in the table). After the reported transactions, the filing shows 1,221,389 and 1,239,011 shares beneficially owned by Aldel LLC in the related lines, and the reporting person disclaims beneficial ownership except for his pecuniary interest. The sales were made pursuant to a 10b5-1 trading plan adopted on August 9, 2024, and the filer offers to provide trade-level execution details on request.